Results from an ITN study published today in the Journal of the American Medical Association demonstrated successful weaning of anti-rejection drugs in pediatric liver transplant recipients (results here). Results from this multicenter pilot study, led by Sandy Feng, MD, PhD (University of California, San Francisco), suggest that certain children undergoing liver transplantation from a parental living donor may be able to maintain their organ without the burdens of lifetime immunosuppression.This study enrolled 20 highly-selected pediatri